Recor Medical
Recor Medical is a medical technology company founded in 2009, based in Palo Alto, California. It specializes in developing innovative therapies for hypertension using ultrasound technology. As a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., Recor Medical is part of the larger Otsuka Holdings Co., Ltd. group. The company's flagship product is the Paradise Ultrasound Renal Denervation system, which treats hypertension by denervating the renal arteries. This FDA-approved system has undergone rigorous testing, showing effectiveness and safety in lowering blood pressure for various patients. Recor Medical also operates the Global Paradise System Registry in the EU and the UK to validate the Paradise system's effectiveness in real-world settings. The company is dedicated to improving patient health and well-being, emphasizing compassion, respect, and collaboration in its mission.
Work at Recor Medical in HR or recruiting? Claim this page
Headcount trend
Recor Medical went from 143 employees in Jul 2023 to 230 in Jun 2025. Jan to Jun 2025: 27 people joined, 10 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Hiring now
See all jobsH-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 1 filings.
Peer reviews
Worked with someone at Recor Medical?
Anonymous peer reviews on OffTheRecord
Similar companies
Recor Medical FAQ
How many employees does Recor Medical have?
Recor Medical has about 230 employees, up 2.7% over the 3 months to Jun 2025.
Does Recor Medical sponsor H1B visas?
Yes. Recor Medical filed 1 H1B (LCA) application in FY2026, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.
What is Recor Medical's revenue per employee?
Recor Medical makes about $26K in revenue per employee, based on $6M annual revenue and 230 employees.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.